Quinn Opportunity Partners’s Axsome Therapeutics AXSM Stock Holding History

Quinn Opportunity Partners’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,000	Closed	-$231K	–	202
2021 Q3	$231K	Hold	7,000	–	–	0.01%	228
2021 Q2	$472K	Hold	7,000	–	–	0.03%	182
2021 Q1	$396K	Hold	7,000	–	–	0.03%	204
2020 Q4	$570K	Hold	7,000	–	–	0.05%	159
2020 Q3	$499K	Sell	7,000 -2,000	-22%	-$156K	0.05%	144
2020 Q2	$741K	Buy	+9,000	New	+$693K	0.09%	113

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return